Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Free Cash Flow: 2015-2024

Historic Free Cash Flow for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$135.7 million.

  • Anaptysbio's Free Cash Flow fell 170.30% to -$27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$145.3 million, marking a year-over-year decrease of 40.56%. This contributed to the annual value of -$135.7 million for FY2024, which is 11.58% down from last year.
  • As of FY2024, Anaptysbio's Free Cash Flow stood at -$135.7 million, which was down 11.58% from -$121.6 million recorded in FY2023.
  • In the past 5 years, Anaptysbio's Free Cash Flow ranged from a high of -$14.7 million in FY2020 and a low of -$135.7 million during FY2024.
  • Moreover, its 3-year median value for Free Cash Flow was -$121.6 million (2023), whereas its average is -$110.4 million.
  • As far as peak fluctuations go, Anaptysbio's Free Cash Flow soared by 79.06% in 2020, and later crashed by 221.11% in 2021.
  • Yearly analysis of 5 years shows Anaptysbio's Free Cash Flow stood at -$14.7 million in 2020, then plummeted by 221.11% to -$47.3 million in 2021, then plummeted by 56.39% to -$74.0 million in 2022, then slumped by 64.44% to -$121.6 million in 2023, then fell by 11.58% to -$135.7 million in 2024.